LABORATORY SKIN CARE

Issued Hydroxysome® patents on core technology and applications provide a unique and defensible competitive advantage... • 88% of all API drugs and consumer bio-actives currently do not have any dermal delivery options other than Hydroxysomes® due to incompatible chemistries, molecular weight limitations, or instability issues

Also known as: dermal delivery, LABORATORY SKIN CARE, INC.